CIK 0001540159
- Non-accelerated filer
- Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 905-475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President & CEO sold 4,000 shares at $1.25 ($5,000)
- 4 Open-market sale Former Director sold 7,047 shares at $1.31 ($9,260)
- 4 Open-market sale President & CEO sold 3,000 shares at $1.31 ($3,930)
- 4 Open-market sale Director sold 4,366 shares at $0.81 ($3,515)
- 4 Open-market sale Director sold 32,300 shares at an average $0.79 ($25,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 11 of 14 · 261 filings